EKSO — Ekso Bionics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $13.62m
- $12.23m
- $17.93m
- 37
- 57
- 22
- 32
Annual cashflow statement for Ekso Bionics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.8 | -9.76 | -15.1 | -15.2 | -11.3 |
| Depreciation | |||||
| Non-Cash Items | 5.37 | -1.49 | 2.08 | 2.03 | 2.4 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.08 | -0.468 | -2.58 | -0.583 | -2.52 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.76 | -11.2 | -14.7 | -12.1 | -9.85 |
| Capital Expenditures | 0 | -0.059 | -0.194 | -0.157 | -0.037 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -4.98 | 0 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.059 | -5.17 | -0.157 | -0.037 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.7 | 38.7 | 0 | 0.348 | 7.77 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.99 | 27.5 | -19.9 | -11.9 | -2.15 |